POTENTIAL ANTIVIRAL OF CATECHINS AND THEIR DERIVATIVES TO INHIBIT SARS-COV-2 RECEPTORS OF M pro PROTEIN AND SPIKE GLYCOPROTEIN IN COVID-19 THROUGH THE IN SILICO APPROACH
Catechin and their derivatives have been studied to have antiviral potential against COVID-19 through in silico method “pharmacokinetics screening and molecular docking”. Pharmacokinetics and toxicity profiles were obtained through the ADMETSAR server and SwissADME server. Then proceed with the pre...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | Indonesian |
| Published: |
Syiah Kuala University
2020-09-01
|
| Series: | Jurnal Kedokteran Hewan |
| Subjects: | |
| Online Access: | https://jurnal.usk.ac.id/JKH/article/view/16652 |
| _version_ | 1797278939159199744 |
|---|---|
| author | Frengki Frengki Deddi Prima Putra Fatma Sri Wahyuni Daan Khambri Henni Vanda Vivi Sofia |
| author_facet | Frengki Frengki Deddi Prima Putra Fatma Sri Wahyuni Daan Khambri Henni Vanda Vivi Sofia |
| author_sort | Frengki Frengki |
| collection | DOAJ |
| description | Catechin and their derivatives have been studied to have antiviral potential against COVID-19 through in silico method “pharmacokinetics
screening and molecular docking”. Pharmacokinetics and toxicity profiles were obtained through the ADMETSAR server and SwissADME server. Then proceed with the prediction of affinity through the method molecular docking using the software application MOE 2007.09. The test
material is in the form of a 3D catechin structure and its derivatives as well as several control ligands downloaded via Pubmed. While template
the Receptor M pro protein and the Spike glycoprotein are downloaded from pdb.org (PDB ID: 6LU7 and 6LXT). The pharmacokinetic profile of catechins is relatively better than all control ligands with the lowest toxicity. Molecular docking results also show that catechins and their
derivatives have a stronger affinity than control ligands. This research proves that catechin has antiviral potential through inhibition of M
pro protein and Spike glycoprotein COVID-19 virus. |
| first_indexed | 2024-03-07T16:17:18Z |
| format | Article |
| id | doaj.art-d43b6637d3da4744ad11142c703063cc |
| institution | Directory Open Access Journal |
| issn | 1978-225X 2502-5600 |
| language | Indonesian |
| last_indexed | 2024-03-07T16:17:18Z |
| publishDate | 2020-09-01 |
| publisher | Syiah Kuala University |
| record_format | Article |
| series | Jurnal Kedokteran Hewan |
| spelling | doaj.art-d43b6637d3da4744ad11142c703063cc2024-03-04T10:29:00ZindSyiah Kuala UniversityJurnal Kedokteran Hewan1978-225X2502-56002020-09-0114310.21157/j.ked.hewan.v14i3.1665211552POTENTIAL ANTIVIRAL OF CATECHINS AND THEIR DERIVATIVES TO INHIBIT SARS-COV-2 RECEPTORS OF M pro PROTEIN AND SPIKE GLYCOPROTEIN IN COVID-19 THROUGH THE IN SILICO APPROACHFrengki Frengki0Deddi Prima Putra1Fatma Sri Wahyuni2Daan Khambri3Henni Vanda4Vivi Sofia5Faculty of Veterinary Medicine, Universitas Syiah Kuala, Banda Aceh, IndonesiaFaculty of Pharmacy, Andalas University, Padang, West Sumatra, IndonesiaFaculty of Pharmacy, Andalas University, Padang, West Sumatra, IndonesiaFaculty of Medicine, Andalas University, Padang, West Sumatra, IndonesiaFaculty of Veterinary Medicine, Universitas Syiah Kuala, Banda Aceh, IndonesiaFaculty of Pharmacy, Ahmad Dahlan University, Yogyakarta, IndonesiaCatechin and their derivatives have been studied to have antiviral potential against COVID-19 through in silico method “pharmacokinetics screening and molecular docking”. Pharmacokinetics and toxicity profiles were obtained through the ADMETSAR server and SwissADME server. Then proceed with the prediction of affinity through the method molecular docking using the software application MOE 2007.09. The test material is in the form of a 3D catechin structure and its derivatives as well as several control ligands downloaded via Pubmed. While template the Receptor M pro protein and the Spike glycoprotein are downloaded from pdb.org (PDB ID: 6LU7 and 6LXT). The pharmacokinetic profile of catechins is relatively better than all control ligands with the lowest toxicity. Molecular docking results also show that catechins and their derivatives have a stronger affinity than control ligands. This research proves that catechin has antiviral potential through inhibition of M pro protein and Spike glycoprotein COVID-19 virus.https://jurnal.usk.ac.id/JKH/article/view/16652catechin, stereoisomer, covid-19, in silico |
| spellingShingle | Frengki Frengki Deddi Prima Putra Fatma Sri Wahyuni Daan Khambri Henni Vanda Vivi Sofia POTENTIAL ANTIVIRAL OF CATECHINS AND THEIR DERIVATIVES TO INHIBIT SARS-COV-2 RECEPTORS OF M pro PROTEIN AND SPIKE GLYCOPROTEIN IN COVID-19 THROUGH THE IN SILICO APPROACH Jurnal Kedokteran Hewan catechin, stereoisomer, covid-19, in silico |
| title | POTENTIAL ANTIVIRAL OF CATECHINS AND THEIR DERIVATIVES TO INHIBIT SARS-COV-2 RECEPTORS OF M pro PROTEIN AND SPIKE GLYCOPROTEIN IN COVID-19 THROUGH THE IN SILICO APPROACH |
| title_full | POTENTIAL ANTIVIRAL OF CATECHINS AND THEIR DERIVATIVES TO INHIBIT SARS-COV-2 RECEPTORS OF M pro PROTEIN AND SPIKE GLYCOPROTEIN IN COVID-19 THROUGH THE IN SILICO APPROACH |
| title_fullStr | POTENTIAL ANTIVIRAL OF CATECHINS AND THEIR DERIVATIVES TO INHIBIT SARS-COV-2 RECEPTORS OF M pro PROTEIN AND SPIKE GLYCOPROTEIN IN COVID-19 THROUGH THE IN SILICO APPROACH |
| title_full_unstemmed | POTENTIAL ANTIVIRAL OF CATECHINS AND THEIR DERIVATIVES TO INHIBIT SARS-COV-2 RECEPTORS OF M pro PROTEIN AND SPIKE GLYCOPROTEIN IN COVID-19 THROUGH THE IN SILICO APPROACH |
| title_short | POTENTIAL ANTIVIRAL OF CATECHINS AND THEIR DERIVATIVES TO INHIBIT SARS-COV-2 RECEPTORS OF M pro PROTEIN AND SPIKE GLYCOPROTEIN IN COVID-19 THROUGH THE IN SILICO APPROACH |
| title_sort | potential antiviral of catechins and their derivatives to inhibit sars cov 2 receptors of m pro protein and spike glycoprotein in covid 19 through the in silico approach |
| topic | catechin, stereoisomer, covid-19, in silico |
| url | https://jurnal.usk.ac.id/JKH/article/view/16652 |
| work_keys_str_mv | AT frengkifrengki potentialantiviralofcatechinsandtheirderivativestoinhibitsarscov2receptorsofmproproteinandspikeglycoproteinincovid19throughtheinsilicoapproach AT deddiprimaputra potentialantiviralofcatechinsandtheirderivativestoinhibitsarscov2receptorsofmproproteinandspikeglycoproteinincovid19throughtheinsilicoapproach AT fatmasriwahyuni potentialantiviralofcatechinsandtheirderivativestoinhibitsarscov2receptorsofmproproteinandspikeglycoproteinincovid19throughtheinsilicoapproach AT daankhambri potentialantiviralofcatechinsandtheirderivativestoinhibitsarscov2receptorsofmproproteinandspikeglycoproteinincovid19throughtheinsilicoapproach AT hennivanda potentialantiviralofcatechinsandtheirderivativestoinhibitsarscov2receptorsofmproproteinandspikeglycoproteinincovid19throughtheinsilicoapproach AT vivisofia potentialantiviralofcatechinsandtheirderivativestoinhibitsarscov2receptorsofmproproteinandspikeglycoproteinincovid19throughtheinsilicoapproach |